SCHEMBL6171969

SCHEMBL6171969

COc1ccc2c(C(C)C(=O)O)c(C(=O)c3cc(C)ccn3)[nH]c2c1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 9/20 0.67
PTGS1 P23219 7/20 0.59
TDP1 Q9NUW8 1/20 0.44
DYRK1A Q13627 3/20 0.43
ACHE P22303 2/20 0.43
BCHE P06276 1/20 0.43
KDM4E B2RXH2 2/20 0.41
ALDH1A1 P00352 2/20 0.41
HPGD P15428 2/20 0.41
HSD17B10 Q99714 2/20 0.41
DYRK3 O43781 1/20 0.41
CCNT1 O60563 1/20 0.41
CCNB2 O95067 1/20 0.41
CYP1A2 P05177 1/20 0.41
CDK1 P06493 1/20 0.41
CYP3A4 P08684 1/20 0.41
ADRA2A P08913 1/20 0.41
CYP2D6 P10635 1/20 0.41
CCNB1 P14635 1/20 0.41
ADRA2B P18089 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6168891 0.92 PTGS2 (0.67) PTGS2PTGS1KDM4EALDH1A1HPGD
SCHEMBL6172104 0.89 PTGS2 (0.53) PTGS2PTGS1
SCHEMBL6181624 0.85 PTGS2 (0.66) PTGS2PTGS1CCNB2CDK1CCNB1
SCHEMBL6170598 0.85 PTGS2 (0.48) PTGS2PTGS1DYRK1AACHEBCHE
SCHEMBL6171712 0.84 PTGS2 (0.68) PTGS2PTGS1
SCHEMBL6170156 0.83 PTGS2 (0.50) PTGS2PTGS1MAPT
SCHEMBL6170712 0.83 PTGS2 (0.53) PTGS2PTGS1ACHEBCHEKDM4E
SCHEMBL6171600 0.82 PTGS2 (0.58) PTGS2PTGS1MAPT
SCHEMBL6171784 0.81 PTGS2 (0.69) PTGS2PTGS1KDM4EPOLB
SCHEMBL6169677 0.80 PTGS2 (1.00) PTGS2PTGS1DYRK1AACHEBCHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1045833-B1 2,3-SUBSTITUTED INDOLE COMPOUNDS AS COX-2 INHIBITORS PFIZER (US) 2005-11-02 EP claimed
US-6608070-B1 Useful for treatment of medical condition in which prostaglandins are implicated as pathogens NAKAO KAZUNARI (JP) 2003-08-19 US claimed
US-6608070-B1 Useful for treatment of medical condition in which prostaglandins are implicated as pathogens NAKAO KAZUNARI (JP) 2003-08-19 US disclosed